CELU (Celularity) Total Liabilities: $145.39 Mil (As of Dec. 2025)


CELU Celularity Inc CELU
31 GF Score
Price $0.75
GF Value $2.28
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Celularity Total Liabilities?

Celularity CELU -9.16% 31 Total Liabilities is $145.39 Mil as of Dec. 2025. GuruFocus rates CELU with a GF Score™ of 31/100 and a GF Value™ of $2.28 (Possible Value Trap). The stock has 5 warning signs investors should review.

Celularity's Total Liabilities for the quarter that ended in Dec. 2025 was $145.39 Mil.

Celularity's quarterly Total Liabilities declined from Jun. 2025 ($145.78 Mil) to Sep. 2025 ($134.33 Mil) but then increased from Sep. 2025 ($134.33 Mil) to Dec. 2025 ($145.39 Mil).

Celularity's annual Total Liabilities increased from Dec. 2023 ($102.93 Mil) to Dec. 2024 ($123.85 Mil) and increased from Dec. 2024 ($123.85 Mil) to Dec. 2025 ($145.39 Mil).

Celularity Total Liabilities Historical Data

* Premium members only.

The historical data trend for Celularity's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celularity Total Liabilities Chart

Celularity Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial 314.71 202.17 102.93 123.85 145.39

Celularity Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.85 134.38 145.78 134.33 145.39
CELU
31GF Score
Celularity Inc CELU
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Celularity Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Celularity's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=80.759+(26.898+34.923
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.811+0+0)
=145.39

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=107.329--38.062
=145.39

Celularity's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=80.759+(26.898+34.923
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.811+0+0)
=145.39

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=107.329--38.062
=145.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $145.39 Mil mean?
Celularity (CELU) has a Total Liabilities of $145.39 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Celularity and its competitors.
Is Celularity's Total Liabilities too high?
Celularity's current Total Liabilities is $145.39 Mil. Overall, Celularity has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Celularity's Total Liabilities compare to GRTX and BCDA?
Celularity's Total Liabilities of $145.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Celularity and its competitors. Celularity's current Total Liabilities is $145.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celularity stock overvalued right now?
Based on GuruFocus' analysis, Celularity (CELU) is currently considered Possible Value Trap. The stock's GF Value™ is $2.28, compared to a current price of $0.75 — trading 67.1% below its estimated fair value. The current Total Liabilities is $145.39 Mil. Celularity's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Celularity (CELU), the current Total Liabilities is $145.39 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Celularity (CELU) Overvalued in 2026?

Based on GuruFocus' analysis, Celularity stock appears to be undervalued. The current stock price of $0.75 is trading 67.1% below its estimated GF Value™ of $2.28. GuruFocus considers Celularity to be Possible Value Trap.

Key valuation signals for CELU:

  • Total Liabilities: $145.39 Mil
  • GF Value™: $2.28 vs. price of $0.75 (67.1% below fair value)
  • GF Score™: 31/100 with 5 warning signs

No single metric tells the full story. See the CELU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Celularity Business Description

Address 170 Park Avenue, Florham Park, NJ, USA, 07932
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
31GF Score

Get the complete analysis for CELU

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.75
Price
$2.28
GF Value